PMS-DEFEROXAMINE 2 G
DEFEROXAMINE MESYLATE : 2 G · DIN 02243450 · PHARMASCIENCE INC
Health Canada status: CANCELLED POST MARKET
What is PMS-DEFEROXAMINE?
PMS-DEFEROXAMINE 2 G contains DEFEROXAMINE MESYLATE : 2 G. It is listed in the Health Canada Drug Product Database under DIN 02243450, held by PHARMASCIENCE INC, supplied as POWDER FOR SOLUTION for INTRAVENOUS ; SUBCUTANEOUS ; INTRAMUSCULAR ; INTRAPERITONEAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Sep-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02243450 |
|---|---|
| Brand name | PMS-DEFEROXAMINE |
| Generic / active ingredient | DEFEROXAMINE MESYLATE : 2 G |
| Manufacturer | PHARMASCIENCE INC |
| Strength | 2 G |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS ; SUBCUTANEOUS ; INTRAMUSCULAR ; INTRAPERITONEAL |
| Schedule | Prescription |
| ATC code | V03AC01 DEFEROXAMINE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Sep-2017 |
What can be used instead?
Other Canadian products sharing ATC code V03AC01 DEFEROXAMINE. 3 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DEFEROXAMINE MESYLATE FOR INJECTION | 2 G | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02247022 |
| DEFEROXAMINE MESYLATE FOR INJECTION | 500 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02241600 |
| DESFERAL 500MG | 500 MG | POWDER FOR SOLUTION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | DIN 01981242 |
| DEFEROXAMINE MESYLATE FOR INJECTION | 2 G | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02261820 |
| DESFERAL 2G | 2 G | POWDER FOR SOLUTION | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 01981250 |
| PMS-DEFEROXAMINE | 500 MG | POWDER FOR SOLUTION | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02242055 |
Who else supplies DEFEROXAMINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DEFEROXAMINE appears in 22 registered pack listings across 11 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.